|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 130.50 SAR | +0.31% |
|
-1.58% | +17.89% |
| 06-09 | Morgan Stanley Raises Sabic Agri-Nutrients PT, Affirms at Equalweight | MT |
| 05-18 | Sabic Agri-Nutrients, SALIC Extend Food Security MoU | MT |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 24.68 | 27.38 | 8.69 | 7.46 | 9.63 | |||||
Return on Total Capital | 28.83 | 33.43 | 11.31 | 9.79 | 11.97 | |||||
Return On Equity % | 44.78 | 55.06 | 19.43 | 17.97 | 21.37 | |||||
Return on Common Equity | 44.1 | 56.63 | 19.45 | 18.37 | 21.79 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 68.79 | 58.78 | 41.41 | 36.26 | 38.71 | |||||
SG&A Margin | 7.49 | 4.33 | 6.6 | 7.97 | 7.35 | |||||
EBITDA Margin % | 69.8 | 58.39 | 40.96 | 35.6 | 37.39 | |||||
EBITA Margin % | 61.3 | 54.13 | 33 | 27.44 | 30.95 | |||||
EBIT Margin % | 61.3 | 54.13 | 32.98 | 27.42 | 30.93 | |||||
Income From Continuing Operations Margin % | 58.79 | 55.11 | 35.02 | 31.12 | 34.17 | |||||
Net Income Margin % | 54.5 | 52.88 | 33.17 | 30.08 | 33.05 | |||||
Net Avail. For Common Margin % | 54.5 | 52.88 | 33.17 | 30.08 | 33.05 | |||||
Normalized Net Income Margin | 35.28 | 33.71 | 22.66 | 20.13 | 22.56 | |||||
Levered Free Cash Flow Margin | 22.85 | 37.26 | 42.34 | 17.41 | 11.3 | |||||
Unlevered Free Cash Flow Margin | 22.93 | 37.3 | 42.43 | 17.48 | 11.31 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.64 | 0.81 | 0.42 | 0.44 | 0.5 | |||||
Fixed Assets Turnover | 1.33 | 2.19 | 1.29 | 1.31 | 1.57 | |||||
Receivables Turnover (Average Receivables) | 6.4 | 7.47 | 5.35 | 7.01 | 8.27 | |||||
Inventory Turnover (Average Inventory) | 5.39 | 10.85 | 9.09 | 9.96 | 11.4 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 6.38 | 6.84 | 3.69 | 3.97 | 6.44 | |||||
Quick Ratio | 5.76 | 6.37 | 3.4 | 3.68 | 6.01 | |||||
Operating Cash Flow to Current Liabilities | 3.51 | 4.74 | 1.53 | 1.15 | 2.2 | |||||
Days Sales Outstanding (Average Receivables) | 57 | 48.86 | 68.27 | 52.18 | 44.16 | |||||
Days Outstanding Inventory (Average Inventory) | 67.78 | 33.65 | 40.16 | 36.74 | 32.03 | |||||
Average Days Payable Outstanding | 15.73 | 21.27 | 41.39 | 38.82 | 40.92 | |||||
Cash Conversion Cycle (Average Days) | 109.05 | 61.24 | 67.04 | 50.1 | 35.27 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 1.05 | 1.17 | 1.13 | 0.99 | 0.96 | |||||
Total Debt / Total Capital | 1.04 | 1.16 | 1.12 | 0.98 | 0.96 | |||||
LT Debt/Equity | 0.92 | 1.06 | 1.05 | 0.9 | 0.84 | |||||
Long-Term Debt / Total Capital | 0.91 | 1.05 | 1.04 | 0.89 | 0.83 | |||||
Total Liabilities / Total Assets | 13.96 | 22.5 | 25.7 | 23.55 | 17.36 | |||||
EBIT / Interest Expense | 448.9 | 888.86 | 219.13 | 257.53 | 1.19K | |||||
EBITDA / Interest Expense | 513.65 | 961.81 | 273.75 | 336.39 | 1.45K | |||||
(EBITDA - Capex) / Interest Expense | 462.97 | 895.18 | 220.24 | 270.7 | 1.22K | |||||
Total Debt / EBITDA | 0.03 | 0.02 | 0.05 | 0.05 | 0.04 | |||||
Net Debt / EBITDA | -0.83 | -1.15 | -2.38 | -2.86 | -2.58 | |||||
Total Debt / (EBITDA - Capex) | 0.03 | 0.02 | 0.06 | 0.06 | 0.05 | |||||
Net Debt / (EBITDA - Capex) | -0.93 | -1.23 | -2.96 | -3.55 | -3.07 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 188.26 | 97.88 | -41.87 | 0.25 | 18.22 | |||||
Gross Profit, 1 Yr. Growth % | 296.26 | 69.52 | -59.05 | -12.22 | 26.23 | |||||
EBITDA, 1 Yr. Growth % | 264.51 | 67.63 | -59.34 | -12.99 | 25.92 | |||||
EBITA, 1 Yr. Growth % | 354.72 | 77.28 | -64.67 | -16.77 | 35.77 | |||||
EBIT, 1 Yr. Growth % | 354.72 | 77.28 | -64.69 | -16.79 | 35.8 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 335.69 | 85.5 | -63.06 | -10.92 | 29.8 | |||||
Net Income, 1 Yr. Growth % | 303.89 | 91.98 | -63.54 | -9.08 | 29.9 | |||||
Normalized Net Income, 1 Yr. Growth % | 299.78 | 89.1 | -60.92 | -11.08 | 32.49 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 253.52 | 91.98 | -63.54 | -9.08 | 29.9 | |||||
Accounts Receivable, 1 Yr. Growth % | 430.27 | 1.61 | -38.83 | 1.34 | -0.69 | |||||
Inventory, 1 Yr. Growth % | 75.84 | 3.57 | -6.2 | 5.6 | -6.51 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 51.78 | -0.67 | -1.23 | -1.61 | -0.75 | |||||
Total Assets, 1 Yr. Growth % | 98 | 36.28 | -6.48 | 0.85 | 5.82 | |||||
Tangible Book Value, 1 Yr. Growth % | 91.32 | 27.89 | -10.77 | 4.22 | 14.85 | |||||
Common Equity, 1 Yr. Growth % | 90.56 | 27.93 | -10.82 | 4.12 | 14.78 | |||||
Cash From Operations, 1 Yr. Growth % | 143.92 | 126.73 | -51.06 | -27.63 | 28.97 | |||||
Capital Expenditures, 1 Yr. Growth % | 181.59 | 16.04 | 15.36 | -12.95 | 1.02 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 61.86 | 214.34 | -34.12 | -58.8 | -21.93 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 61.93 | 213.52 | -34.04 | -58.74 | -22.12 | |||||
Dividend Per Share, 1 Yr. Growth % | 112.5 | 182.35 | -50 | 0 | 16.67 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 70.81 | 138.83 | 7.25 | -23.66 | 8.87 | |||||
Gross Profit, 2 Yr. CAGR % | 97.36 | 158.85 | -16.68 | -40.05 | 5.26 | |||||
EBITDA, 2 Yr. CAGR % | 89.8 | 145.64 | -17.33 | -40.48 | 3.95 | |||||
EBITA, 2 Yr. CAGR % | 111.8 | 181.9 | -20.74 | -45.73 | 5.35 | |||||
EBIT, 2 Yr. CAGR % | 111.8 | 181.9 | -20.77 | -45.75 | 5.35 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 95.61 | 184.29 | -17.22 | -42.64 | 7.53 | |||||
Net Income, 2 Yr. CAGR % | 88.34 | 178.46 | -16.34 | -42.42 | 8.68 | |||||
Normalized Net Income, 2 Yr. CAGR % | 91.59 | 174.95 | -14.04 | -41.01 | 8.54 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 76.2 | 160.52 | -16.34 | -42.42 | 8.68 | |||||
Accounts Receivable, 2 Yr. CAGR % | 99.95 | 132.12 | -21.16 | -21.27 | 0.32 | |||||
Inventory, 2 Yr. CAGR % | 27.79 | 34.95 | -1.44 | -0.48 | -0.64 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 20.05 | 22.78 | -0.95 | -1.42 | -1.18 | |||||
Total Assets, 2 Yr. CAGR % | 43.11 | 64.53 | 12.9 | -2.88 | 3.3 | |||||
Tangible Book Value, 2 Yr. CAGR % | 39.75 | 56.42 | 6.82 | -3.57 | 9.41 | |||||
Common Equity, 2 Yr. CAGR % | 39.45 | 56.13 | 6.81 | -3.64 | 9.32 | |||||
Cash From Operations, 2 Yr. CAGR % | 69.5 | 135.42 | 5.34 | -40.49 | -3.39 | |||||
Capital Expenditures, 2 Yr. CAGR % | -4.12 | 80.76 | 15.7 | 0.21 | -6.23 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 132.67 | 128.55 | 44.1 | -47.88 | -43.79 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 131.78 | 128.29 | 44 | -47.81 | -43.81 | |||||
Dividend Per Share, 2 Yr. CAGR % | 19.02 | 144.95 | 18.82 | -29.29 | 8.01 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 35.45 | 79.4 | 49.12 | 4.87 | -11.68 | |||||
Gross Profit, 3 Yr. CAGR % | 45.75 | 87.45 | 40 | -15.22 | -23.16 | |||||
EBITDA, 3 Yr. CAGR % | 44.7 | 81.35 | 35 | -15.87 | -23.94 | |||||
EBITA, 3 Yr. CAGR % | 51.34 | 98.65 | 41.21 | -19.4 | -26.77 | |||||
EBIT, 3 Yr. CAGR % | 51.34 | 98.65 | 41.18 | -19.42 | -26.78 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 48.03 | 92.18 | 43.99 | -15.17 | -24.69 | |||||
Net Income, 3 Yr. CAGR % | 44.34 | 89.54 | 41.4 | -13.98 | -24.49 | |||||
Normalized Net Income, 3 Yr. CAGR % | 44.59 | 90.76 | 43.48 | -13.02 | -22.75 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 38.07 | 81.31 | 35.26 | -13.98 | -24.49 | |||||
Accounts Receivable, 3 Yr. CAGR % | 65.48 | 59.56 | 48.82 | -14.28 | -14.93 | |||||
Inventory, 3 Yr. CAGR % | 13.43 | 19.14 | 19.54 | 0.85 | -2.53 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 14.81 | 12.7 | 14.19 | -1.17 | -1.2 | |||||
Total Assets, 3 Yr. CAGR % | 27.69 | 40.95 | 36.29 | 8.73 | -0.07 | |||||
Tangible Book Value, 3 Yr. CAGR % | 25.41 | 35.68 | 29.73 | 5.95 | 2.22 | |||||
Common Equity, 3 Yr. CAGR % | 25.29 | 35.5 | 29.55 | 5.91 | 2.15 | |||||
Cash From Operations, 3 Yr. CAGR % | 34.84 | 86.9 | 39.46 | -7.05 | -22.98 | |||||
Capital Expenditures, 3 Yr. CAGR % | 5.17 | 2.18 | 55.63 | 5.23 | 0.48 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 39.84 | 159.48 | 51.11 | -5.05 | -40.72 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 39.2 | 158.58 | 51.05 | -5.04 | -40.71 | |||||
Dividend Per Share, 3 Yr. CAGR % | 19.35 | 58.74 | 44.22 | 12.18 | -16.45 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 27.42 | 47.06 | 23.38 | 27.46 | 31.48 | |||||
Gross Profit, 5 Yr. CAGR % | 37.01 | 56.22 | 16.48 | 18.81 | 24.9 | |||||
EBITDA, 5 Yr. CAGR % | 35.97 | 53.43 | 15.38 | 16.2 | 21.63 | |||||
EBITA, 5 Yr. CAGR % | 42.9 | 65.61 | 16.51 | 18.29 | 25.64 | |||||
EBIT, 5 Yr. CAGR % | 42.9 | 65.61 | 16.49 | 18.27 | 25.62 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 40.34 | 64.12 | 17.32 | 18.49 | 28.12 | |||||
Net Income, 5 Yr. CAGR % | 38.23 | 62.76 | 16.05 | 17.68 | 27.27 | |||||
Normalized Net Income, 5 Yr. CAGR % | 38.6 | 62.42 | 17.44 | 19.29 | 28.37 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 34.6 | 58.48 | 13 | 14.59 | 23.92 | |||||
Accounts Receivable, 5 Yr. CAGR % | 38.37 | 48.16 | 23.01 | 20.29 | 27.1 | |||||
Inventory, 5 Yr. CAGR % | 11.16 | 12.15 | 7.23 | 10.87 | 11.02 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 9.78 | 8.69 | 8.23 | 6.82 | 7.77 | |||||
Total Assets, 5 Yr. CAGR % | 19.19 | 26.52 | 21.63 | 21.44 | 21.99 | |||||
Tangible Book Value, 5 Yr. CAGR % | 18.49 | 23.82 | 17.62 | 18.36 | 21.18 | |||||
Common Equity, 5 Yr. CAGR % | 18.46 | 23.73 | 17.55 | 18.23 | 21.04 | |||||
Cash From Operations, 5 Yr. CAGR % | 26.73 | 52.83 | 22.21 | 18.25 | 20.42 | |||||
Capital Expenditures, 5 Yr. CAGR % | -3.5 | 1.37 | 9.26 | 1.39 | 27.08 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 33.93 | 82.01 | 42.27 | 36.61 | 1.76 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 33.05 | 80.58 | 41.84 | 36.41 | 1.72 | |||||
Dividend Per Share, 5 Yr. CAGR % | 11.2 | 46.97 | 19.14 | 14.87 | 28.47 |
- Stock Market
- Stocks
- 2020 Stock
- Financials SABIC Agri-Nutrients Company
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















